Innoviva (INVA) Common Equity (2010 - 2026)

Innoviva's Common Equity history runs 17 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• Quarterly Common Equity rose 107.4% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 107.4% YoY) and the FY2025 annual result came in at $1.2 billion, up 69.69% from the prior year.
• Common Equity was $1.3 billion for Q1 2026 at Innoviva, up from $1.2 billion in the prior quarter.
• Across five years, Common Equity topped out at $1.3 billion in Q1 2026 and bottomed at $552.2 million in Q1 2022.
• A 5-year average of $727.0 million and a median of $665.5 million in 2024 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity slipped 20.74% — and 2026, when it soared 107.4%.
• Innoviva's Common Equity stood at $565.8 million in 2022, then grew by 19.29% to $675.0 million in 2023, then advanced by 2.4% to $691.2 million in 2024, then jumped by 69.69% to $1.2 billion in 2025, then grew by 14.39% to $1.3 billion in 2026.
• Business Quant data shows INVA's Common Equity at $1.3 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.0 billion in Q3 2025.